IDT 10-K Annual Report July 31, 2017 | Alphaminr

IDT 10-K Fiscal year ended July 31, 2017

IDT CORP
10-Qs and 10-Ks
10-Q
Quarter ended Jan. 31, 2025
10-Q
Quarter ended Oct. 31, 2024
10-K
Fiscal year ended July 31, 2024
10-Q
Quarter ended April 30, 2024
10-Q
Quarter ended Jan. 31, 2024
10-Q
Quarter ended Oct. 31, 2023
10-K
Fiscal year ended July 31, 2023
10-Q
Quarter ended April 30, 2023
10-Q
Quarter ended Jan. 31, 2023
10-Q
Quarter ended Oct. 31, 2022
10-K
Fiscal year ended July 31, 2022
10-Q
Quarter ended April 30, 2022
10-Q
Quarter ended Jan. 31, 2022
10-Q
Quarter ended Oct. 31, 2021
10-K
Fiscal year ended July 31, 2021
10-Q
Quarter ended April 30, 2021
10-Q
Quarter ended Jan. 31, 2021
10-Q
Quarter ended Oct. 31, 2020
10-K
Fiscal year ended July 31, 2020
10-Q
Quarter ended April 30, 2020
10-Q
Quarter ended Jan. 31, 2020
10-Q
Quarter ended Oct. 31, 2019
10-K
Fiscal year ended July 31, 2019
10-Q
Quarter ended April 30, 2019
10-Q
Quarter ended Jan. 31, 2019
10-Q
Quarter ended Oct. 31, 2018
10-K
Fiscal year ended July 31, 2018
10-Q
Quarter ended April 30, 2018
10-Q
Quarter ended Jan. 31, 2018
10-Q
Quarter ended Oct. 31, 2017
10-K
Fiscal year ended July 31, 2017
10-Q
Quarter ended April 30, 2017
10-Q
Quarter ended Jan. 31, 2017
10-Q
Quarter ended Oct. 31, 2016
10-K
Fiscal year ended July 31, 2016
10-Q
Quarter ended April 30, 2016
10-Q
Quarter ended Jan. 31, 2016
10-Q
Quarter ended Oct. 31, 2015
10-K
Fiscal year ended July 31, 2015
10-Q
Quarter ended April 30, 2015
10-Q
Quarter ended Jan. 31, 2015
10-Q
Quarter ended Oct. 31, 2014
10-K
Fiscal year ended July 31, 2014
10-Q
Quarter ended April 30, 2014
10-Q
Quarter ended Jan. 31, 2014
10-Q
Quarter ended Oct. 31, 2013
10-K
Fiscal year ended July 31, 2013
10-Q
Quarter ended April 30, 2013
10-Q
Quarter ended Jan. 31, 2013
10-Q
Quarter ended Oct. 31, 2012
10-K
Fiscal year ended July 31, 2012
10-Q
Quarter ended April 30, 2012
10-Q
Quarter ended Jan. 31, 2012
10-Q
Quarter ended Oct. 31, 2011
10-K
Fiscal year ended July 31, 2011
10-Q
Quarter ended April 30, 2011
10-Q
Quarter ended Jan. 31, 2011
10-Q
Quarter ended Oct. 31, 2010
10-K
Fiscal year ended July 31, 2010
10-Q
Quarter ended April 30, 2010
10-Q
Quarter ended Jan. 31, 2010
PROXIES
DEF 14A
Filed on Nov. 1, 2024
DEF 14A
Filed on Nov. 1, 2023
DEF 14A
Filed on Nov. 3, 2022
DEF 14A
Filed on Nov. 12, 2021
DEF 14A
Filed on Oct. 30, 2020
DEF 14A
Filed on Nov. 8, 2019
DEF 14A
Filed on Nov. 16, 2018
DEF 14A
Filed on Nov. 6, 2017
DEF 14A
Filed on Nov. 8, 2016
DEF 14A
Filed on Oct. 30, 2015
DEF 14A
Filed on Oct. 31, 2014
DEF 14A
Filed on Nov. 5, 2013
DEF 14A
Filed on Nov. 7, 2012
DEF 14A
Filed on Nov. 7, 2011
DEF 14A
Filed on Feb. 28, 2011
DEF 14A
Filed on Nov. 3, 2010
TABLE OF CONTENTS
Part IprintItem 1. BusinessprintItem 1A. Risk FactorsprintItem 1B. Unresolved Staff CommentsprintItem 2. PropertiesprintItem 3. Legal ProceedingsprintItem 4. Mine Safety DisclosuresprintPart IIprintItem 5. Market For Registrant S Common Equity, Related Stockholder Matters and Issuer Purchases Of Equity SecuritiesprintItem 6. Selected Financial DataprintItem 7. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsprintItem 7A. Quantitative and Qualitative Disclosures About Market RisksprintItem 8. Financial Statements and Supplementary DataprintItem 9. Changes in and Disagreements with Accountants on Accounting and Financial DisclosureprintItem 9A. Controls and ProceduresprintItem 9B. Other InformationprintPart IIIprintItem 10. Directors, Executive Officers and Corporate GovernanceprintItem 11. Executive CompensationprintItem 12. Security Ownership Of Certain Beneficial Owners and Management and Related Stockholder MattersprintItem 13. Certain Relationships and Related Transactions, and Director IndependenceprintItem 14. Principal Accounting Fees and ServicesprintPart IVprintItem 15. Exhibits, Financial Statement SchedulesprintNote 1 Description Of Business and Summary Of Significant Accounting PoliciesprintNote 2 Investment in Rafael Pharmaceuticals, IncprintNote 3 Idt Financial Services Holding Limited Assets and Liabilities Held For SaleprintNote 4 Zedge Spin-offprintNote 5 Sale Of Interest in Fabrix Systems LtdprintNote 6 Marketable SecuritiesprintNote 7 Fair Value MeasurementsprintNote 8 Derivative InstrumentsprintNote 9 Property, Plant and EquipmentprintNote 10 GoodwillprintNote 11 Sale Of Member Interest in Visa Europe LtdprintNote 12 Other Operating Losses, NetprintNote 13 Revolving Credit Loan PayableprintNote 14 Accrued ExpensesprintNote 15 Severance ExpenseprintNote 16 Other Income (expense), NetprintNote 17 Income TaxesprintNote 18 EquityprintNote 19 Stock-based CompensationprintNote 20 Accumulated Other Comprehensive Income (loss)printNote 21 Commitments and ContingenciesprintNote 22 Related Party TransactionsprintNote 23 Defined Contribution PlansprintNote 24 Business Segment InformationprintNote 25 Selected Quarterly Financial Data (unaudited)print

Exhibits

10.09(9) Stock Grant Agreement between the Registrant and Howard Jonas, dated December 27, 2012. 10.10* Stock Option Agreement between the Registrant and Howard Jonas, dated May 2, 2017. 10.11* Assignment Agreement between the Registrant and Howard Jonas, dated September 19, 2017. 21.01* Subsidiaries of the Registrant. 23.01* Consent ofBDO USA, LLP 23.02* Consent ofGrant Thornton LLP 31.01* Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.02* Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 32.01* Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.02* Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.